Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer

Figure 6

Establishment of a risk score-based nomogram for predicting prognosis of gastric cancer. The nomogram that integrates the risk score and stage for predicting one-, three-, and five-year survival probability in the (a) training set and the (b) GSE66229 dataset. ROCs of one-, three-, and five-year survival based on the nomogram in (c) the training set and (d) the GSE66229 dataset. Calibration curves showing the relationships between nomogram-predicted one-, three-, and five-year survival and actual survival duration in (e–g) the training set and (h–j) the GSE66229 dataset.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)